220 related articles for article (PubMed ID: 30896671)
1. Association of TFPI polymorphisms rs8176592, rs10931292, and rs10153820 with venous thrombosis: A meta-analysis.
Zhang Y; Pang A; Zhao L; Guo Q; Zhang Z; Zhu X; Wei R; Yin X; Wang B; Li X
Medicine (Baltimore); 2019 Mar; 98(12):e14978. PubMed ID: 30896671
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of tissue factor pathway inhibitor plasma levels.
Dennis J; Kassam I; Morange PE; Trégouët DA; Gagnon F
Thromb Haemost; 2015 Aug; 114(2):245-57. PubMed ID: 25879386
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss.
Guerra-Shinohara EM; Bertinato JF; Tosin Bueno C; Cordeiro da Silva K; Burlacchini de Carvalho MH; Pulcineli Vieira Francisco R; Zugaib M; Cerda A; Morelli VM
Thromb Haemost; 2012 Oct; 108(4):693-700. PubMed ID: 22918506
[TBL] [Abstract][Full Text] [Related]
4. Association between thrombin-activatable fibrinolysis inhibitor gene polymorphisms and venous thrombosis risk: a meta-analysis.
Wang W; Ma H; Lu L; Sun G; Liu D; Zhou Y; Tong Y; Lu Z
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):419-30. PubMed ID: 26656901
[TBL] [Abstract][Full Text] [Related]
5. Association of XPA polymorphism with breast cancer risk: A meta-analysis.
Zhang Y; Guo Q; Yin X; Zhu X; Zhao L; Zhang Z; Wei R; Wang B; Li X
Medicine (Baltimore); 2018 Jun; 97(26):e11276. PubMed ID: 29953005
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
Opstad TB; Eilertsen AL; Høibraaten E; Skretting G; Sandset PM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):516-21. PubMed ID: 20453636
[TBL] [Abstract][Full Text] [Related]
7. Association study to evaluate TFPI gene in CAD in Han Chinese.
Zhao Y; Yu Y; Shi M; Yang X; Li X; Jiang F; Chen Y; Tian X
BMC Cardiovasc Disord; 2017 Jul; 17(1):188. PubMed ID: 28716011
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
9. Correlations between methylenetetrahydrofolate reductase gene polymorphisms and venous thromboembolism: A meta-analysis of 99 genetic association studies.
Zeng J; Zeng Q
Eur J Prev Cardiol; 2019 Jan; 26(2):120-134. PubMed ID: 30466296
[TBL] [Abstract][Full Text] [Related]
10. Impact of genetic polymorphisms in thrombin activatable fibrinolysis inhibitor (TAFI) on venous thrombosis disease: A meta-analysis.
Qian K; Xu J; Wan H; Fu F; Lu J; Lin Z; Liu Z; Liu H
Gene; 2015 Sep; 569(2):173-81. PubMed ID: 26071134
[TBL] [Abstract][Full Text] [Related]
11. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms with plasma TFPI level: Boon or curse for DVT patients - Study from India.
Kamal K; Amit S; Kanwaljeet S; Ravi R; Hareram P; Ravi K; Kumar KV; Pravas M; Renu S
Blood Cells Mol Dis; 2017 Jul; 66():31-36. PubMed ID: 28810169
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
[TBL] [Abstract][Full Text] [Related]
14. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
15. Association analysis of tissue factor pathway inhibitor polymorphisms and haplotypes with osteonecrosis of the femoral head in the Korean population.
Dai XL; Hong JM; Oh B; Cho YS; Lee JY; Park EK; Kim CY; Kim SY; Kim TH
Mol Cells; 2008 Nov; 26(5):490-5. PubMed ID: 18695356
[TBL] [Abstract][Full Text] [Related]
16. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
Song Y; Yang Y; Liu L; Liu X
Gene; 2019 May; 698():186-197. PubMed ID: 30849545
[TBL] [Abstract][Full Text] [Related]
17. Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis.
Zhao J; Li D; Tang H; Tang L
Reprod Biol Endocrinol; 2020 Mar; 18(1):18. PubMed ID: 32164758
[TBL] [Abstract][Full Text] [Related]
18. Gene polymorphism of XRCC1 Arg399Gln and cervical carcinoma susceptibility in Asians: a meta-analysis based on 1,759 cases and 2,497 controls.
Liu YT; Shi JP; Fu LY; Zhou B; Wang HL; Wu XM
Asian Pac J Cancer Prev; 2013; 14(1):189-93. PubMed ID: 23534722
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.
Amini-Nekoo A; Futers TS; Moia M; Mannucci PM; Grant PJ; Ariëns RA
Br J Haematol; 2001 May; 113(2):537-43. PubMed ID: 11380428
[TBL] [Abstract][Full Text] [Related]
20. Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease.
Naji DH; Tan C; Han F; Zhao Y; Wang J; Wang D; Fa J; Li S; Chen S; Chen Q; Xu C; Wang QK
Mol Genet Genomics; 2018 Feb; 293(1):119-128. PubMed ID: 28894953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
